StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$13.92−2.76 (-16.55%)

Close on Nov 17, 2026Market cap $1.01BP/E –Yield –

Omeros operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Omeros's operating cash flow for the twelve months ending Jun 30, 2026 was -$68.67M. For fiscal 2025 it was -$116.09M. The highest annual figure on record is $74.73M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$116.09M–
FY2024Dec 31, 2024-$148.80M-299.1%
FY2023Dec 31, 2023$74.73M–
FY2022Dec 31, 2022-$86.48M–
FY2021Dec 31, 2021-$109.72M–
FY2020Dec 31, 2020-$100.09M–
FY2019Dec 31, 2019-$60.07M–
FY2018Dec 31, 2018-$103.74M–
FY2017Dec 31, 2017-$36.23M–
FY2016Dec 31, 2016-$51.50M–
FY2015Dec 31, 2015-$65.21M–
FY2014Dec 31, 2014-$58.04M–
FY2013Dec 31, 2013-$29.70M–
FY2012Dec 31, 2012-$34.55M–
FY2011Dec 31, 2011-$25.67M–
FY2010Dec 31, 2010-$14.50M–
FY2009Dec 31, 2009-$19.03M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.15M–
Q1 FY2026Mar 31, 2026-$14.51M–
Q4 FY2025Dec 31, 2025-$39.84M–
Q3 FY2025Sep 30, 2025-$18.47M–
Q2 FY2025Jun 30, 2025-$21.94M–
Q1 FY2025Mar 31, 2025-$35.84M–
Q4 FY2024Dec 31, 2024-$28.98M–
Q3 FY2024Sep 30, 2024-$32.06M–
Q2 FY2024Jun 30, 2024-$45.99M–
Q1 FY2024Mar 31, 2024-$41.78M-123.9%
Q4 FY2023Dec 31, 2023-$34.83M–
Q3 FY2023Sep 30, 2023-$32.65M–
Q2 FY2023Jun 30, 2023-$32.34M–
Q1 FY2023Mar 31, 2023$174.54M–
Q4 FY2022Dec 31, 2022-$25.38M–
Q3 FY2022Sep 30, 2022-$26.44M–
Q2 FY2022Jun 30, 2022-$19.47M–
Q1 FY2022Mar 31, 2022-$15.19M–
Q4 FY2021Dec 31, 2021-$18.22M–
Q1 FY2021Mar 31, 2021-$40.25M–
Q4 FY2020Dec 31, 2020-$18.41M–
Q3 FY2020Sep 30, 2020-$34.94M–
Q2 FY2020Jun 30, 2020-$37.60M–
Q1 FY2020Mar 31, 2020-$9.14M–
Q4 FY2019Dec 31, 2019-$23.01M–
Q3 FY2019Sep 30, 2019-$7.52M–
Q2 FY2019Jun 30, 2019-$16.59M–
Q1 FY2019Mar 31, 2019-$12.95M–
Q4 FY2018Dec 31, 2018-$24.66M–
Q3 FY2018Sep 30, 2018-$36.87M–
Q2 FY2018Jun 30, 2018-$30.91M–
Q1 FY2018Mar 31, 2018-$11.30M–
Q4 FY2017Dec 31, 2017-$4.17M–
Q3 FY2017Sep 30, 2017-$11.19M–
Q2 FY2017Jun 30, 2017-$8.16M–
Q1 FY2017Mar 31, 2017-$12.70M–
Q4 FY2016Dec 31, 2016-$10.86M–
Q3 FY2016Sep 30, 2016-$11.22M–
Q2 FY2016Jun 30, 2016-$12.80M–

More Omeros figures

See a number that looks wrong?